Source-grounded facts extracted from NEPHROS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NEPHROS INC reported first quarter ended March 31, 2026 results: revenue $5.2 million, net income $140,000.
“Net revenue was $5.2 million, compared to $4.9 million in the first quarter of 2025, up 7% ● Net income was $140,000, compared to a net income of $558,000 in the first quarter of 2025”
Alisa Lask departed as Director at NEPHROS INC.
“On April 23, 2025, Alisa Lask notified the Board of Directors (the “Board”) of Nephros, Inc. (the “Company”) that she will not stand for re-election to the Board at the Company’s annual meeting of stockholders scheduled to be held on June 16, 2025 (the “2025 Annual Meeting”).”
NEPHROS INC reported first quarter ended March 31, 2024 results: revenue $3.5 million, net income Net loss of $0.2 million.
“Nephros Announces Financial Results for Quarter Ended March 31, 2024 First-Quarter Net Revenue of $3.5 Million”
NEPHROS INC reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue Net revenue from continuing operations was $14.2 million, net income Net loss from continuing operations was ($1.6 million).
“Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.